Pharmacokinetic considerations in the obese
- 9 March 2011
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Anaesthesiology
- Vol. 25 (1), 27-36
- https://doi.org/10.1016/j.bpa.2010.12.002
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- Quantification of Lean BodyweightClinical Pharmacokinetics, 2005
- A Standard Weight Descriptor for Dose Adjustment in the Obese PatientClinical Pharmacokinetics, 2004
- Effects of Obesity on PharmacokineticsClinical Pharmacokinetics, 2000
- Clinical Pharmacokinetics of Cisatracurium BesilateClinical Pharmacokinetics, 1999
- Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1993
- Pharmacokinetics and Pharmacodynamics of Vecuronium in the Obese Surgical PatientAnesthesia & Analgesia, 1992
- Pharmacokinetic Implications for the Clinical Use of PropofolClinical Pharmacokinetics, 1989
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987
- Prolonged Accumulation of Diazepam in ObesityThe Journal of Clinical Pharmacology, 1983